Company Overview and News

35
The Ratings Game: iPhone lines were shorter this year, though that might not mean much for Apple

14h marketwatch
First-day buyers were generally more interested in large-screen iPhone XS Max, according to one former analyst
S AAPL

34
A Deeper Dive Into Sibanye-Stillwater + A Few Updates

15h seekingalpha
By acquiring Lonmin (OTC:LNMIF) Sibanye (SBGL) aims to become Nr. 2 platinum miner in the world. When the deal was announced on December 14, 2017, Lonmin shares went 20% up. SBGL, 4.6% down. Despite the ambitions, both companies are currently facing many problems on their own:
HHRBF S LNMIF

39
Top Analyst Reports for Netflix, EOG Resources & Simon Property Group

19h zacks - 1
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Netflix (NFLX), EOG Resources (EOG) and Simon Property Group (SPG). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
WFCNP TXN NFLX MS WFC UNP EOG S SPG

35
Smith Micro Software Turns Profitable

2018-09-20 seekingalpha
The company managed to squeeze its first (non-GAAP) profitability in quite a while and things look set to improve from here.
CHTR S CMCSA SMSI

48
Kimco (KIM) Announces Sprouts Store Opening at Lincoln Square

2018-09-20 zacks
Kimco Realty Corp. (KIM - Free Report) is making every effort to add value to its properties. Recently, the company announced the opening of the 32,000-square-foot store of the natural food grocer — Sprouts Farmers Market, Inc. (SFM - Free Report) — at its iconic mixed-use development, Lincoln Square, at Philadelphia’s Center City District. This marks Sprouts Farmers Market's foray into Pennsylvania.
TGT SFM S SBUX LB KIM

34
S / Sprint Corporation 425 (Prospectus)

2018-09-19 sec.gov
425 Filed by Sprint Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended
S

34
Telefonica Brasil accelerates content push with Tidal deal

2018-09-19 reuters
SAO PAULO, Sept 19 (Reuters) - Telefonica Brasil SA has signed a partnership deal with music streaming app Tidal, Brazil’s largest telecoms firm said on Wednesday as it continues to expand its content offerings.
S

49
5 Stocks to Buy Amid a Prolonged Trade War Slump

2018-09-19 investorplace
Yesterday, President Donald Trump announced a new round of tariffs on Chinese goods — $200 billion to be exact. In response, China issued a $60 billion levy on U.S. goods. In an increasingly global economy, prospects for a trade war with China tend to foster nervousness among investors.
DLTR X S T TMUS DG VZ SAVE STZ CGC LUV

35
Sprint (S) Unveils Wireless Protection Plan Sprint Complete

2018-09-17 zacks - 1
Sprint Corporation (S - Free Report) recently introduced a protection plan, Sprint Complete. The company’s new protection plan offers wireless protection, enhanced repair service as well as technology support for select smartphones, tablets and smartwatches.
S WIN GJH UZA USM TNAV UZC UZB

58
5 5G Stocks to Buy That Will Stream Higher Profits for Investors

2018-09-14 investorplace - 4
As telcos launch the first of the 5G networks, 5G stocks will become a focus. The technology will change wireless. How much speed it will add has become a point of controversy. Estimates from a few years ago predicted the improvement at 1,000 times 4G.
BRK.A S T TMUS AAPL CSCO NOK INTC

34
S / Sprint Corporation 425 (Prospectus)

2018-09-13 sec.gov
425 Filed by Sprint Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended
S

41
Telecom Stock Roundup: Verizon 5G Internet Service, Ericsson-T-Mobile 5G Deal & More

2018-09-13 zacks
In the past five trading days, the uptrend in telecom stocks continued driven by healthy job growth data exhibiting signs of a strengthening economy. The stocks were also fueled by optimism from a U.S. proposal to initiate talks with China in the near future to iron out the trade-related differences between the two countries. Per the U.S. Labor Department report, about 201,000 new jobs were created in August, marking the 95th straight month of employment gains in the country.
FNSR ARRS S TMUSP TMUS JNPR VZ VZA

34
S / Sprint Corporation 425 (Prospectus)

2018-09-12 sec.gov
425 Filed by Sprint Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended
S

89
10 Super Safe Growth Stocks to Buy for Long-Lasting Dividends

2018-09-12 investorplace
Whenever the stock market marches higher, it pushes the prices of many companies higher along with it. But as investors bid up good and bad businesses alike, that can make it hard to discern which companies are the best dividend stocks for long-term investors.
LOW TXN ADP VZA HON AMT AAPL CCI CBS HON TMUSP CBS.A TMUS BDX COST CBS.WD MDT HRL S T ADPVV VZ CPV

39
The Paused T-Mobile-Sprint Merger Endangers Sprint Stock

2018-09-12 investorplace
Shares in T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) barely budged on word that regulators have “stopped the clock” on their merger. The original deal between the two, signed in April, valued Sprint stock at about $6.50 per share, but it is an all-stock transaction, about 1/10th of a T-Mobile stock share (specifically 0.10256) for each Sprint stock share.
S T TMUS VZ VZA

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to S / Sprint Corporation on message board site Silicon Investor.

Dinou0027s Bar u0026 Grill Dinou0027s Bar u0026 Grill Dinou0027s Bar u0026 Grill Tell a joke - anything goes Tell a joke - anything goes Tell a joke - anything goes
Humble1 and Swing Trading Friends Humble1 and Swing Trading Friends Humble1 and Swing Trading Friends Income Investing Income Investing Income Investing
Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Fake News Fake News Fake News
Politics for Conservatives Politics for Conservatives Politics for Conservatives The Financial Collapse of 2001 Unwinding The Financial Collapse of 2001 Unwinding The Financial Collapse of 2001 Unwinding
SPX Cycles SPX Cycles SPX Cycles Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives
CUSIP: 85207U105